NeuroOne Medical Technologies Corporation (NMTC) Net margin 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) net profit margin by fiscal year — reported net income divided by reported revenue.
-39.6%FY2025 · since FY2021: -5584.3% → -39.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -39.6% | +317.1 pp |
| FY2024 | -356.7% | +250.7 pp |
| FY2023 | -607.4% | +5234.5 pp |
| FY2022 | -5842.0% | -257.7 pp |
| FY2021 | -5584.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →